Daniel DeAngelo, MD
Myelofibrosis Specialist
I am involved with clinical protocols designed to treat patients with de novo or relapsed acute myelogenous leukemia (AML), acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML) as well as novel therapeutic approaches for the patient with myelodysplasia.
My current research interests include novel immunotherapeutic approaches to the treatment of acute myelogenous leukemia and myelodysplasia. I am currently developing leukemia tumor vaccines from patients with AML or advanced myelodysplasia and will be assaying for immunological and serological responses.
Dana Farber Cancer Institute: 450 Brookline Ave, Boston, MA 02215, USA
Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.